sb 203580 has been researched along with concanavalin a in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayala, A; Chaudry, IH; Chung, CS; Song, GY | 1 |
1 other study(ies) available for sb 203580 and concanavalin a
| Article | Year |
|---|---|
Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK.
Topics: Animals; Bacterial Infections; Cell Division; Concanavalin A; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Imidazoles; Immune Tolerance; Interferon-gamma; Interleukin-10; Interleukin-2; Male; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Spleen; Th1 Cells; Th2 Cells | 2000 |